Anti-monocyte chemoattractant protein 1 gene therapy attenuates experimental chronic pancreatitis induced by dibutyltin dichloride in rats

Gut

Volumn 54, Issue 12, 2005, Pages 1759-1767

  Zhao, H F ^a   Ito, T ^a   Gibo, J ^a   Kawabe, K ^a   Oono, T ^a   Kaku, T ^a   Arita, Y ^a   Zhao, Q W ^a   Usui, M ^a   Egashira, K ^a   Nawata, H ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; AMYLASE; CHEMOKINE; CHEMOKINE RECEPTOR ANTAGONIST; CYTOKINE; CYTOKINE ANTIBODY; DIBUTYLTIN DICHLORIDE; HYDROXYPROLINE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MUTANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHEMICAL ANALYSIS; CHRONIC PANCREATITIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE COURSE; GENE THERAPY; HISTOLOGY; LEG MUSCLE; MACROPHAGE; MALE; MONOCYTE; MORPHOLOGY; NONHUMAN; PANCREATITIS; PLASMID; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; THIGH;

ACTINS; ANIMALS; BLOTTING, WESTERN; CHEMOKINE CCL2; CHEMOKINES; CYTOKINES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FIBROSIS; GENE THERAPY; HYDROXYPROLINE; INJECTIONS, INTRAMUSCULAR; MALE; ORGANOTIN COMPOUNDS; PANCREAS; PANCREATITIS, CHRONIC; RATS; RATS, INBRED LEW; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 28144441864     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2004.049403     Document Type: Article

References (34)

1. Dimagno EP, Layer P, Clain JE. Chronic pancreatitis. In: Go VLW, Di Magno EP, Gardner JD, et al. The pancreas: biology, pathology and disease, 2nd edn. New York: Raven, 1993:665-706.
2. Rollins BJ. Chemokines. Blood 1997;90:909-28.
3. Valente AJ, Rozek MM, Schwartz CJ, et al. Characterization of monocyte chemoattractant protein-1 binding to human monocytes. Biochem Biophys Res Commun 1991;176:309-14.
4. Taub DD, Proost P, Murphy WJ, et al. Monocyte chemotatic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. J Clin Invest 1995;95:1370-6.
5. Sparmann G, Merkord J, Jaschke A, et al. Pancreatic fibrosis in experimental pancreatitis induced by dibutyltin dichloride. Gastroenterology 1997;112:1664-72.
6. Merkord J, Jonas L, Weber H, et al. Acute interstitial pancreatitis in rats induced by dibutyltin dichloride (DBTC): pathogenesis and natural course of lesions. Pancreas 1997;15:392-401.
7. Saurer L, Reber P, Schaffner T, et al. Differential expression of chemokines in normal pancreas and in chronic pancreatitis. Gastroenterology 2000;118:356-67.
8. Grady T, Liang P, Ernst S, et al. Chemokine gene expression in rat pancreatic acinar cells is an early event associated with acute pancreatitis. Gastroenterology 1997;113:1966-75.
9. Demols A, Van Laethem JL, Quertinmont E, et al. N-acetylcysteine decreases severity of acute pancreatitis in mice. Pancreas 2000;20:161-9.
10. Inoue M, Ino Y, Gibo J, et al. The role of MCP-1 (monocyte chemoattractant protein-1) in experimental chronic pancreatitis model induced by dibutyltin dichloride in rats. Pancreas 2002;25:e64-70.
11. Zhang YJ, Rollins BJ. A dominant negative inhibitor indicates that monocyte chemoattractant protein 1 functions as a dimmer. Mol Cell Biol 1995;15:4851-5.
12. Zhang YJ, Rutledge BJ, Rollins BJ. Structure/activity analysis of human monocyte chemoattractant protein-1 (MCP-1) by mutagenesis: identification of a mutated protein that inhibits MCP-1-mediated monocyte chemotaxis. J Biol Chem 1994;269:15918-24.
13. Egashira K, Koyanagi M, Kitamoto S, et al. Anti-monocyte chemoattractant protein-1 gene therapy inhibits vascular remodeling in rats: blockade of MCP-1 activity after intramuscular transfer of a mutant gene inhibits vascular remodeling induced by chronic blockade of NO synthesis. FASEB J 2000;14:1974-8.
14. Ueki T, Kaneda Y, Tsutsui H, et al. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med 1999;5:226-30.
15. Ceska M, Briath K, Brown B. A?new and rapid method for the clinical determination of α-amylase activities in human serum and urine. Clin Chim Acta 1969;26:437-44.
16. Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:267-85.
17. Weidenbach H, Lerch MM, Turi S, et al. Failure of a prolyl 4-hydroxylase inhibitor to alter extracellular matrix deposition during experimental pancreatitis. Digestion 1997;58:50-7.
18. Varela L, Margot I. Tumor necrosis factor-α: a multifunctional regular of mammary gland development. Endocrinology 1996;137:4915-24.
19. Takano S, Kimura T, Yamaguchi H, et al. Effects of stress on the development of chronic pancreatitis. Pancreas 1992;7:548-55.
20. Damoiseaux JG, Dopp EA, Calame W, et al. Rat macrophage lysosomal membrane antigen recognised by monoclonal antibody ED1. Immunology 1994;83:140-7.
21. Reyes-Reyna SM, Krolick KA. Chemokine production by rat monocytes exposed to interferon-gamma. Clin Immunol 2000;94:105-13.
22. Strate T, Yekebas E, Knoefel WT, et al. Pathogenesis and the natural course of chronic pancreatitis. Eur J Gastroenterol Hepatol 2002;14:929-34.
23. Rollins BJ. Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease. Mol Med Today 1996;2:198-204.
24. Madhav B, Mark B, Sheila S, et al. Inflammatory mediators in acute pancreatitis. J Pathol 2000;190:117-25.
25. Apte MV, Haber PS, Applegate TL, et al. Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture. Gut 1998;43:128-33.
26. Apte MV, Haber PS, Darby SJ, et al. Pancreatic stellate cells are activated by proinflammatory cytokines: implications for pancreatic fibrogenesis. Gut 1999;44:534-41.
27. Phillips PA, Wu MJ, Kumar RK, et al. Cell migrations novel aspect of pancreatic stellate cell biology. Gut 2003;52:677-82.
28. Gibo J, Ito T, Kawabe K, et al. Camostat mesilate attenuates pancreatic fibrosis via inhibition of monocytes and pancreatic stellate cells activity. Lab Invest 2005;85:75-89.
29. Masamune A, Kikuta K, Satoh M, et al. Ligands of peroxisome proliferator-activated receptor gamma block activation of pancreatic stellate cells. J Biol Chem 2002;277:141-7.
30. Kitamoto S, Egashira K. Anti-monocyte chemoattractant protein-1 gene therapy for cardiovascular diseases. Expert Rev Cardiovasc Ther 2003;1:393-400.
31. Inoshima I, Kuwano K, Hamada N, et al. Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary fibrosis in mice. Am J Physiol Lung Cell Mol Physiol 2004;286:L1038-44.
32. Wada T, Furuichi K, Sakai N, et al. Gene therapy via blockade of monocyte chemoattractant protein-1 for renal fibrosis. J Am Soc Nephrol 2004;15:940-8.
33. Tsuruta S, Nakamuta M, Enjoji M, et al. Anti-monocyte chemoattractant protein-1 gene therapy prevents dimethylnitrosamine-induced hepatic fibrosis in rats. Int J Mol Med 2004;14:337-42.
34. Imamura M, Ogawa T, Sasaguri Y, et al. Suppression of macrophage infiltration inhibits activation of hepatic stellate cells and liver fibrogenesis in rats. Gastroenterology 2005;128:138-46.